Clinical Trials Directory

Trials / Completed

CompletedNCT05877833

Evaluating the Safety and Performance Characteristics of Ephemeral® Tattoo Ink in Healthy Subjects

An Open-Label, Single-Center, Prospective, Observational, Clinical Use Study Evaluating the Safety and Performance Characteristics of Ephemeral® Tattoo Ink in Healthy Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Ephemeral Solutions Inc. · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

An Open-Label, Single-Center, Prospective, Observational, Clinical Use Study Evaluating the Safety and Performance Characteristics of Ephemeral® Tattoo Ink in Healthy Subjects

Detailed description

Study product will be applied at the baseline visit by a skilled tattoo artist. The tattoo design will be approximately 2 inches x 2 inches and will consist of line work. No filling or shading will be included in the design.

Conditions

Interventions

TypeNameDescription
OTHERVibrancy AssessmentAdditionally, important medical events that may not result in death, be life threatening, or require hospitalization may be considered SAEs when, based on appropriate medical judgment, they may jeopardize the subject and may require medical or surgical intervention to prevent one of the outcomes listed above.

Timeline

Start date
2020-08-10
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2023-05-26
Last updated
2023-05-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05877833. Inclusion in this directory is not an endorsement.